We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLE:NASDAQSuper League Enterprise, Inc. Analysis

Data as of 2026-08-31 - not real-time

$4.01

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Super League Enterprise, Inc. is neutral at $4.01, with no clear ordering between short and long averages. It has gained 48.0% over the past 30 days. Relative strength is 55.4 — neutral — and the MACD signal is bullish. Watch $2.12 as support and $7.37 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 0.0 versus a 16.1 sector average, below the peer group. Consensus targets land 166.0% above where the shares trade now.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 251.2%, a beta of -1.37 and a maximum drawdown of 97.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Motley Fool Transcribing, The Motley Fool Aug 15, 2026 0 Image source: The Motley Fool.Management targets profitability by year-end while integrating Misfits Ads.Metaplanet allocates 2,100 BTC $135M to acquire controlling stake in Nasdaq's Super League Enterprise, creating...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 5.20
  • MACD momentum is positive
  • 30-day price change of +48.0%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 0.0 versus sector average of 16.1
  • Trading below the 200-day average of 5.20
  • Analyst targets imply +166.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 0.0 versus sector average of 16.1
  • Negative profit margin of -190.3%
  • Analyst targets imply +166.0% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin-190.33%
P/E Ratio0.0
ROE-503.98%
ROA-64.67%
P/B Ratio0.5
Op. Cash Flow$-11401000
Free Cash Flow$-9981000
Industry P/E16.1

Technical Analysis

TrendNeutral
RSI55.4
Support$2.12
Resistance$7.37
MA 20$3.55
MA 50$3.16
MA 200$5.20
MACDBullish
VolumeIncreasing
Fear & Greed Index94.43

Valuation

Target Price$10.67
Upside/Downside166.00%
GradeUndervalued
TypeValue

Risk Assessment

Beta-1.37
Volatility251.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.